Publicacions en què col·labora amb MANUEL MATA ROIG (9)

2013

  1. Gene Expression Profiles of Metabolic Aggressiveness and Tumor Recurrence in Benign Meningioma

    PLoS ONE, Vol. 8, Núm. 6

2009

  1. Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression

    Journal of Neuro-Oncology, Vol. 95, Núm. 3, pp. 343-354

  2. Metastasizing anaplastic ependymoma in an adult. Chromosomal imbalances, metabolic and gene expression profiles: Correspondence

    Histopathology

  3. Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury

    British Journal of Pharmacology, Vol. 156, Núm. 3, pp. 534-544

2008

  1. The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFRamplification

    Neuropathology, Vol. 28, Núm. 5, pp. 507-515

2006

  1. Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines

    Journal of Immunology, Vol. 176, Núm. 9, pp. 5577-5586

2005

  1. Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells

    Thorax, Vol. 60, Núm. 2, pp. 144-152

2004

  1. Direct evidence of leukocyte adhesion in arterioles by angiotensin II

    Blood, Vol. 104, Núm. 2, pp. 402-408

2003

  1. Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats

    European Respiratory Journal, Vol. 22, Núm. 6, pp. 900-905